<DOC>
	<DOCNO>NCT00249873</DOCNO>
	<brief_summary>The purpose study determine combination clopidogrel 75mg daily ( od ) plus aspirin 100mg daily ( recommend dose ) good aspirin alone ( 100mg daily recommend dose ) prevent vascular event stroke heart attack approximately three year follow-up patient atrial fibrillation associate least one major risk factor vascular event elderly , blood pressure increase , history stroke transient ischemic attack leave ventricular dysfunction etc . The study also accept patient atrial fibrillation unwilling take oral anticoagulant therapy .</brief_summary>
	<brief_title>Atrial Fibrillation Clopidogrel Trial With Irbesartan Prevention Vascular Events ( ACTIVE A )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>To eligible ACTIVE A patient must time three follow condition : Evidence atrial fibrillation either one current Electrocardiogram ( ECG ) two ECGs record two week part 6 month prior study enrollment . Evidence high risk vascular event : least one follow risk criterion must present : 75 year great ; treatment systemic hypertension ; prior stroke , Transient Ischemic Attack ( TIA ) nonCentral Nervous System ( nonCNS ) systemic embolus ; leave ventricular dysfunction leave ventricular ejection fraction ( EF ) estimate echocardiogram angiogram ( radionuclide contrast ) &lt; 45 % ; peripheral vascular disease ( previous peripheral artery revascularization , limb foot amputation , combination current intermittent claudication ankle arm systolic blood pressure ratio &lt; 0.9 ) ; age 55 74 year either ; f1 ) diabetes mellitus require drug therapy , f2 ) document previous myocardial infarction document coronary artery disease . To either contraindication use oral anticoagulant treatment unwilling take oral anticoagulant treatment . Patients exclude ACTIVE follow present : requirement clopidogrel ( recent coronary stent procedure ) requirement oral anticoagulant ( prosthetic mechanical heart valve ) ; prior intolerance ASA clopidogrel ; document peptic ulcer disease within previous 6 month ; prior intracerebral hemorrhage ; significant thrombocytopenia ; ( platelet count &lt; 50 x 10 ( 9 ) /L ) psychosocial reason make study participation impractical ; geographic reason make study participation impractical ; ongoing alcohol abuse ; mitral stenosis , pregnant nursing woman woman child bear potential effective birth control least one month prior start study willing continue birth control duration study ; ( severe comorbid condition patient expect survive 6 month ; patient currently receive investigational pharmacologic agent ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Anticoagulant therapy</keyword>
	<keyword>Thromboembolic prevention</keyword>
</DOC>